Walking After Surgery to Improve Recovery and Outcomes After Surgery, AIRTECH Study
AIRTECH
Ambulation to Improve Recovery With Wearable TECHnology (AIRTECH) Study
2 other identifiers
interventional
240
1 country
1
Brief Summary
This clinical trial evaluates the relationship between walking and sleeping habits and surgical outcomes in patients with lung cancer. Early walking after surgery is associated with decreased or less severe complications. Learning about how much patients walk may be important in improving outcomes after surgery. Information gained from this trial may help researchers develop interventions to improve outcomes after surgery and improve overall quality of life after surgery in patients with lung cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 30, 2020
CompletedFirst Submitted
Initial submission to the registry
February 3, 2021
CompletedFirst Posted
Study publicly available on registry
March 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 2, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 2, 2027
April 16, 2026
April 1, 2026
6.2 years
February 3, 2021
April 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clavien-Dindo postoperative morbidity (POM) score
Two Bayesian probability and inferential models will be utilized: * Model 1: Inferential goals: Probability that POM score in the control arm is greater than F0 or FB arm: mean and 95% Credible Interval * Model 2: Baseline covariates adjusted analysis of model 1 * Performance status * FEV1 * Age * Open vs. Minimally invasive (0 is best, 5 is worst.) 0 - No postoperative complications 1. - Minor complication resolved without intervention 2. - complication requiring pharmaceutical intervention 3. - complication requiring surgical, endoscopic or radiological intervention, 4. - life-threatening complication requiring intensive care 5. - complication leading to the patient's death.
Up to 30 days after surgery
Secondary Outcomes (7)
Differences in steps regained at each postoperative day (Fitbit only arm [F0] and Fitbit integration arm [FB])
Up to 30 days after surgery
Change in quality of life
Baseline to 30 days after surgery
Hospital length of stay
Up to 30 days after surgery
Hospital readmission rate for lung surgery related events
Up to 30 days after surgery
Return of bowel function
Up to 30 days after surgery
- +2 more secondary outcomes
Study Arms (3)
Arm I (usual care)
ACTIVE COMPARATORPatients receive usual care consisting of the clinician educating the patient on the importance of increasing exercise activity in the preoperative period and early ambulation in the postoperative setting.
Arm II (usual care, Fitbit)
ACTIVE COMPARATORPatients receive usual care consisting of the clinician educating the patient on the importance of increasing exercise activity in the preoperative period and early ambulation in the postoperative setting. Patients also receive a Fitbit to monitor step count
Arm III (usual care, Fitbit, Fitbit app)
EXPERIMENTALPatients receive usual care consisting of the clinician educating the patient on the importance of increasing exercise activity in the preoperative period and walking in the postoperative setting. Patients also receive a Fitbit device, install and use the Fitbit app on a smartphone. Postoperative step goals are as follows: Postoperative day (POD) 1: 25% of baseline. Subsequent days will be increased by 10% until patient reaches baseline daily step number. Five automatic daily reminders (delivered by the Fitbit Inspire HR\^TM device itself) to meet a minimum of 250 steps an hour. Postoperatively, patients will be invited to participate in a private group with a leaderboard that consists of step numbers of other participants in the study in an anonymous fashion.
Interventions
Receive usual care
Install and use Fitbit app
Use Fitbit to monitor step count
Ancillary studies
Ancillary studies
Eligibility Criteria
You may qualify if:
- years or older
- English speaking
- Ambulatory preoperatively
- Patients undergoing at least a lobectomy
- Must own a smart phone and be willing to install the Fitbit application (App)
- Adequate internet connection via wifi or wireless network connection with smartphone
- Patients who are not already using a wearable device to track daily steps
You may not qualify if:
- Medical, psychiatric, cognitive or other conditions that compromise the patient's ability to understand the patient information, to give informed consent, to comply with the study protocol or to complete the study.
- Cannot maintain activity monitor in place at the time of consent
- Pregnant patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Garrett L Walsh
M.D. Anderson Cancer Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 3, 2021
First Posted
March 5, 2021
Study Start
November 30, 2020
Primary Completion (Estimated)
February 2, 2027
Study Completion (Estimated)
February 2, 2027
Last Updated
April 16, 2026
Record last verified: 2026-04